GL1X · GenesisL1 explorer

Research workbench

PARP14 macrodomain 2 with inhibitor

Analyse PARP14 macrodomain 2 with inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5O2D
Type
protein
Length
189 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Poly [ADP-ribose] polymerase 14
EC
2.4.2.30
UniProt
Q460N5
Ligands
9HH
Pockets
2 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APoly [ADP-ribose] polymerase 14 (EC 2.4.2.30)protein18940% helix, 18% strandQ460N5

Ligands and binding sites

  • 9HH · ~{N}-[2-(9~{H}-carbazol-1-yl)phenyl]methanesulfonamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11680.820.97259HH
21420.470.7824empty

Compared structures

  • 5O2D · PARP14 Macrodomain 2 with inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • Q460N5 · AlphaFold monomer V2.0 prediction for protein mono-ADP- ribosyltransferase PARP14 (Q460N5) · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.